The US FDA qualifies the first AI drug development tool, AIM-NASH, to help doctors assess a severe form of fatty liver disease in drug trials (Sahil Pandey/Reuters)

Sahil Pandey / Reuters:
The US FDA qualifies the first AI drug development tool, AIM-NASH, to help doctors assess a severe form of fatty liver disease in drug trials  —  The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a severe form …

Posted from: this blog via Microsoft Power Automate.

Daily Deals